Skip to main content

CA 25 LT 250 Pill - blue round, 10mm

Pill with imprint CA 25 LT 250 is Blue, Round and has been identified as Carbidopa and Levodopa 25 mg / 250 mg. It is supplied by Aurobindo Pharma Limited.

Carbidopa/levodopa is used in the treatment of Parkinson's Disease; Neuroleptic Malignant Syndrome; GTP-CH Deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CA 25 LT 250

Carbidopa and levodopa 25 mg / 250 mg CA 25 LT 250

Carbidopa and Levodopa

Imprint
CA 25 LT 250
Strength
25 mg / 250 mg
Color
Blue
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
Manufacturer
APL Healthcare Limited
National Drug Code (NDC)
59651-0458

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.